Drugmaker Lannett Strikes Deal On $511M Debt Restructure
Pennsylvania-based generic-drug maker Lannett Co. on Monday announced it has reached an agreement with the majority of its secured lenders for an equity swap restructuring transaction it expects will cut the...To view the full article, register now.
Already a subscriber? Click here to view full article